145 ent limited Company Information
Company Number
09903639
Website
www.michaelwareing-ent.comRegistered Address
c/o sandison easson & co., rex buildings, wilmslow, cheshire, SK9 1HY
Industry
Specialist medical practice activities
Telephone
02079351304
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
michael john wareing 92.8%
lydia margaret mary wareing 1.8%
View All145 ent limited Estimated Valuation
Pomanda estimates the enterprise value of 145 ENT LIMITED at £267.7k based on a Turnover of £668.2k and 0.4x industry multiple (adjusted for size and gross margin).
145 ent limited Estimated Valuation
Pomanda estimates the enterprise value of 145 ENT LIMITED at £0 based on an EBITDA of £-133.6k and a 3.57x industry multiple (adjusted for size and gross margin).
145 ent limited Estimated Valuation
Pomanda estimates the enterprise value of 145 ENT LIMITED at £2m based on Net Assets of £1m and 1.95x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
145 Ent Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
145 Ent Limited Overview
145 Ent Limited is a live company located in wilmslow, SK9 1HY with a Companies House number of 09903639. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in December 2015, it's largest shareholder is michael john wareing with a 92.8% stake. 145 Ent Limited is a young, small sized company, Pomanda has estimated its turnover at £668.2k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
145 Ent Limited Health Check
Pomanda's financial health check has awarded 145 Ent Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
3 Weak
Size
annual sales of £668.2k, make it larger than the average company (£513.1k)
- 145 Ent Limited
£513.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a faster rate (4.9%)
- 145 Ent Limited
4.9% - Industry AVG
Production
with a gross margin of 55.6%, this company has a comparable cost of product (55.6%)
- 145 Ent Limited
55.6% - Industry AVG
Profitability
an operating margin of -20.3% make it less profitable than the average company (12.9%)
- 145 Ent Limited
12.9% - Industry AVG
Employees
with 6 employees, this is below the industry average (12)
6 - 145 Ent Limited
12 - Industry AVG
Pay Structure
on an average salary of £29.5k, the company has an equivalent pay structure (£29.5k)
- 145 Ent Limited
£29.5k - Industry AVG
Efficiency
resulting in sales per employee of £111.4k, this is more efficient (£78.2k)
- 145 Ent Limited
£78.2k - Industry AVG
Debtor Days
it gets paid by customers after 42 days, this is later than average (33 days)
- 145 Ent Limited
33 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- 145 Ent Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- 145 Ent Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 388 weeks, this is more cash available to meet short term requirements (79 weeks)
388 weeks - 145 Ent Limited
79 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 7.3%, this is a lower level of debt than the average (33.7%)
7.3% - 145 Ent Limited
33.7% - Industry AVG
145 ent limited Credit Report and Business Information
145 Ent Limited Competitor Analysis
Perform a competitor analysis for 145 ent limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
145 ent limited Ownership
145 ENT LIMITED group structure
145 Ent Limited has no subsidiary companies.
Ultimate parent company
145 ENT LIMITED
09903639
145 ent limited directors
145 Ent Limited currently has 6 directors. The longest serving directors include Mr Michael Wareing (Dec 2015) and Miss Imogen Wareing (Jul 2016).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Michael Wareing | United Kingdom | 60 years | Dec 2015 | - | Director |
Miss Imogen Wareing | United Kingdom | 29 years | Jul 2016 | - | Director |
Miss Felicity Wareing | United Kingdom | 27 years | Jul 2016 | - | Director |
Miss Lydia Wareing | United Kingdom | 25 years | Jul 2017 | - | Director |
Mr Henry Wareing | United Kingdom | 20 years | Sep 2021 | - | Director |
Miss Carolyn Higgs | United Kingdom | 60 years | Sep 2021 | - | Director |
145 ENT LIMITED financials
145 Ent Limited's latest turnover from December 2022 is estimated at £668.2 thousand and the company has net assets of £1 million. According to their latest financial statements, 145 Ent Limited has 6 employees and maintains cash reserves of £586.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
---|---|---|---|---|---|---|---|
Turnover | |||||||
Other Income Or Grants | |||||||
Cost Of Sales | |||||||
Gross Profit | |||||||
Admin Expenses | |||||||
Operating Profit | |||||||
Interest Payable | |||||||
Interest Receivable | |||||||
Pre-Tax Profit | |||||||
Tax | |||||||
Profit After Tax | |||||||
Dividends Paid | |||||||
Retained Profit | |||||||
Employee Costs | |||||||
Number Of Employees | 6 | 6 | 5 | 5 | 5 | 6 | 4 |
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
---|---|---|---|---|---|---|---|
Tangible Assets | 10,966 | 10,806 | 12,713 | 12,059 | 10,663 | 8,195 | 4,955 |
Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments & Other | 395,566 | 1,128,887 | 1,122,332 | 835,570 | 232,758 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 406,532 | 1,139,693 | 1,135,045 | 847,629 | 243,421 | 8,195 | 4,955 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 78,136 | 42,296 | 47,730 | 71,826 | 34,770 | 295,075 | 230,714 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 32,148 | 29,258 | 29,412 | 65,982 | 139,217 | 0 | 0 |
Cash | 586,766 | 47,263 | 81,641 | 16,091 | 264,731 | 0 | 0 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 697,050 | 118,817 | 158,783 | 153,899 | 438,718 | 295,075 | 230,714 |
total assets | 1,103,582 | 1,258,510 | 1,293,828 | 1,001,528 | 682,139 | 303,270 | 235,669 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 0 | 0 | 0 | 0 | 0 | 105,482 | 122,820 |
Group/Directors Accounts | 0 | 30 | 1,556 | 2,214 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 50,000 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 78,473 | 77,507 | 75,385 | 105,895 | 154,496 | 0 | 0 |
total current liabilities | 78,473 | 77,537 | 126,941 | 108,109 | 154,496 | 105,482 | 122,820 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
provisions | 1,800 | 30,636 | 41,842 | 8,207 | 4,279 | 0 | 0 |
total long term liabilities | 1,800 | 30,636 | 41,842 | 8,207 | 4,279 | 0 | 0 |
total liabilities | 80,273 | 108,173 | 168,783 | 116,316 | 158,775 | 105,482 | 122,820 |
net assets | 1,023,309 | 1,150,337 | 1,125,045 | 885,212 | 523,364 | 197,788 | 112,849 |
total shareholders funds | 1,023,309 | 1,150,337 | 1,125,045 | 885,212 | 523,364 | 197,788 | 112,849 |
Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
---|---|---|---|---|---|---|---|
Operating Activities | |||||||
Operating Profit | |||||||
Depreciation | 1,935 | 1,907 | 2,244 | 2,128 | |||
Amortisation | 0 | 0 | 0 | 0 | |||
Tax | |||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 38,730 | -5,588 | -60,666 | -36,179 | -121,088 | 64,361 | 230,714 |
Creditors | 0 | 0 | 0 | 0 | -105,482 | -17,338 | 122,820 |
Accruals and Deferred Income | 966 | 2,122 | -30,510 | -48,601 | 154,496 | 0 | 0 |
Deferred Taxes & Provisions | -28,836 | -11,206 | 33,635 | 3,928 | 4,279 | 0 | 0 |
Cash flow from operations | |||||||
Investing Activities | |||||||
capital expenditure | |||||||
Change in Investments | -733,321 | 6,555 | 286,762 | 602,812 | 232,758 | 0 | 0 |
cash flow from investments | |||||||
Financing Activities | |||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | -30 | -1,526 | -658 | 2,214 | 0 | 0 | 0 |
Other Short Term Loans | 0 | -50,000 | 50,000 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
share issue | |||||||
interest | |||||||
cash flow from financing | |||||||
cash and cash equivalents | |||||||
cash | 539,503 | -34,378 | 65,550 | -248,640 | 264,731 | 0 | 0 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 539,503 | -34,378 | 65,550 | -248,640 | 264,731 | 0 | 0 |
P&L
December 2022turnover
668.2k
+63%
operating profit
-135.5k
0%
gross margin
55.6%
+2.06%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
1m
-0.11%
total assets
1.1m
-0.12%
cash
586.8k
+11.41%
net assets
Total assets minus all liabilities
145 ent limited company details
company number
09903639
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
December 2015
age
9
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
c/o sandison easson & co., rex buildings, wilmslow, cheshire, SK9 1HY
last accounts submitted
December 2022
145 ent limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to 145 ent limited.
145 ent limited Companies House Filings - See Documents
date | description | view/download |
---|